Table 3 Clinical outcomes
SCD (n = 124) | ECD (n = 80) | DKT (n = 15) | p value | SCD vs DKT | ECD vs DKT | |
|---|---|---|---|---|---|---|
Patient death (%) | 4 (3.2) | 3 (3.8) | 0 (0) | 0.96 | ||
Graft failure (%) | 4 (3.2) | 2 (2.5) | 1 (6.67) | 0.63 | ||
DGF (%) | 33 (26.6) | 27 (33.8) | 3 (20.0) | 0.41 | ||
Nadir sCr | 1.2 ± 0.7 | 1.3 ± 0.4 | 1.0 ± 0.3 | < 0.01 | 0.10 | < 0.01 |
Time to nadir sCr | 24.6 ± 30.0 | 33.8 ± 34.9 | 22.6 ± 21.3 | 0.02 | 0.47 | 0.04 |
Post-transplant eGFR | ||||||
1 yr | 60.2 ± 15.0 | 48.3 ± 13.9 | 57.0 ± 21.5 | < 0.01 | 0.58 | 0.43 |
2 yr | 64.7 ± 18.3 | 53.1 ± 14.8 | 46.1 ± 17.4 | < 0.01 | 0.03 | 0.23 |
3 yr | 65.8 ± 18.0 | 55.7 ± 17.1 | 50.1 ± 19.1 | 0.01 | 0.15 | 0.99 |
Rejection episode | 40 (32.3) | 31 (38.8) | 6 (40.0) | 0.59 | ||
Complicationsa (%) | 6 (4.8) | 19 (23.8) | 2 (13.3) | < 0.01 | 0.24 | 0.99 |
F/U duration (mo) | 33.5 ± 15.0 | 28.5 ± 13.9 | 25 ± 12.1 | < 0.01 | 0.03 | 0.39 |